Publication
In silico versus in vitro analysis of LDLR mutations
| dc.contributor.author | Alves, A.C. | |
| dc.contributor.author | Silva, S. | |
| dc.contributor.author | Patel, D. | |
| dc.contributor.author | Malhó, R. | |
| dc.contributor.author | Soutar, A.K. | |
| dc.contributor.author | Bourbon, M. | |
| dc.date.accessioned | 2012-07-10T12:47:29Z | |
| dc.date.available | 2012-07-10T12:47:29Z | |
| dc.date.issued | 2012-05 | |
| dc.description.abstract | The LDL receptor (LDLR) is a glycoprotein that mediates binding and internalization of cholesterol-rich lipoproteins from plasma. Mutations in the LDLR gene are the major cause of familial hypercholesterolaemia (FH), which results in impaired catabolism of circulating LDL. This common autosomal inherited metabolism disorder leads to premature atherosclerosis and increased risk of CHD. Many different mutations (currently more than 1300) have been identified in FH patients, but not all give rise to a defective LDLR. | por |
| dc.identifier.uri | http://hdl.handle.net/10400.18/897 | |
| dc.language.iso | eng | por |
| dc.publisher | Instituto Nacional de Saúde Doutor Ricardo Jorge, IP | por |
| dc.subject | Doenças Cardio e Cérebro-vasculares | por |
| dc.title | In silico versus in vitro analysis of LDLR mutations | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Milan, Italy | por |
| oaire.citation.title | 80th European Atherosclerosis Society Congress-EAS, 25-28 May 2012 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | conferenceObject | por |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- IN SILICO VERSUS IN VITRO ANALYSIS OF LDLR MUTATIONS.pdf
- Size:
- 1.26 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: